2018-2023 Global Nuclear Medicine Consumption Market Report

June 2018 | 159 pages | ID: 2F7A1789441EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Nuclear Medicine market for 2018-2023.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.

Over the next five years, LPI(LP Information) projects that Nuclear Medicine will register a 7.6% CAGR in terms of revenue, reach US$ 6610 million by 2023, from US$ 4590 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Tc-99
• I-123/131
• In-111
• Xe-133
• Th-201
• Ga-67
• Other

Segmentation by application:

• Diagnostic
• Therapeutic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• GE Healthcare
• Bracco Imaging
• Mallinckrodt
• Lantheus Medical Imaging
• Bayer
• Triad Isotopes
• Nordion
• Jubilant Pharma
• Eli Lilly
• SIEMENS
• China Isotope & Radiation
• Dongcheng

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Nuclear Medicine consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Nuclear Medicine market by identifying its various subsegments.
• Focuses on the key global Nuclear Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Nuclear Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Nuclear Medicine submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nuclear Medicine Consumption 2013-2023
  2.1.2 Nuclear Medicine Consumption CAGR by Region
2.2 Nuclear Medicine Segment by Type
  2.2.1 Tc-99
  2.2.2 I-123/131
  2.2.3 In-111
  2.2.4 Xe-133
  2.2.5 Th-201
  2.2.6 Ga-67
  2.2.7 Other
2.3 Nuclear Medicine Consumption by Type
  2.3.1 Global Nuclear Medicine Consumption Market Share by Type (2013-2018)
  2.3.2 Global Nuclear Medicine Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Nuclear Medicine Sale Price by Type (2013-2018)
2.4 Nuclear Medicine Segment by Application
  2.4.1 Diagnostic
  2.4.2 Therapeutic
2.5 Nuclear Medicine Consumption by Application
  2.5.1 Global Nuclear Medicine Consumption Market Share by Application (2013-2018)
  2.5.2 Global Nuclear Medicine Value and Market Share by Application (2013-2018)
  2.5.3 Global Nuclear Medicine Sale Price by Application (2013-2018)

3 GLOBAL NUCLEAR MEDICINE BY PLAYERS

3.1 Global Nuclear Medicine Sales Market Share by Players
  3.1.1 Global Nuclear Medicine Sales by Players (2016-2018)
  3.1.2 Global Nuclear Medicine Sales Market Share by Players (2016-2018)
3.2 Global Nuclear Medicine Revenue Market Share by Players
  3.2.1 Global Nuclear Medicine Revenue by Players (2016-2018)
  3.2.2 Global Nuclear Medicine Revenue Market Share by Players (2016-2018)
3.3 Global Nuclear Medicine Sale Price by Players
3.4 Global Nuclear Medicine Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Nuclear Medicine Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Nuclear Medicine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 NUCLEAR MEDICINE BY REGIONS

4.1 Nuclear Medicine by Regions
  4.1.1 Global Nuclear Medicine Consumption by Regions
  4.1.2 Global Nuclear Medicine Value by Regions
4.2 Americas Nuclear Medicine Consumption Growth
4.3 APAC Nuclear Medicine Consumption Growth
4.4 Europe Nuclear Medicine Consumption Growth
4.5 Middle East & Africa Nuclear Medicine Consumption Growth

5 AMERICAS

5.1 Americas Nuclear Medicine Consumption by Countries
  5.1.1 Americas Nuclear Medicine Consumption by Countries (2013-2018)
  5.1.2 Americas Nuclear Medicine Value by Countries (2013-2018)
5.2 Americas Nuclear Medicine Consumption by Type
5.3 Americas Nuclear Medicine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Nuclear Medicine Consumption by Countries
  6.1.1 APAC Nuclear Medicine Consumption by Countries (2013-2018)
  6.1.2 APAC Nuclear Medicine Value by Countries (2013-2018)
6.2 APAC Nuclear Medicine Consumption by Type
6.3 APAC Nuclear Medicine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Nuclear Medicine by Countries
  7.1.1 Europe Nuclear Medicine Consumption by Countries (2013-2018)
  7.1.2 Europe Nuclear Medicine Value by Countries (2013-2018)
7.2 Europe Nuclear Medicine Consumption by Type
7.3 Europe Nuclear Medicine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nuclear Medicine by Countries
  8.1.1 Middle East & Africa Nuclear Medicine Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Nuclear Medicine Value by Countries (2013-2018)
8.2 Middle East & Africa Nuclear Medicine Consumption by Type
8.3 Middle East & Africa Nuclear Medicine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Nuclear Medicine Distributors
10.3 Nuclear Medicine Customer

11 GLOBAL NUCLEAR MEDICINE MARKET FORECAST

11.1 Global Nuclear Medicine Consumption Forecast (2018-2023)
11.2 Global Nuclear Medicine Forecast by Regions
  11.2.1 Global Nuclear Medicine Forecast by Regions (2018-2023)
  11.2.2 Global Nuclear Medicine Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Nuclear Medicine Forecast by Type
11.8 Global Nuclear Medicine Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 GE Healthcare
  12.1.1 Company Details
  12.1.2 Nuclear Medicine Product Offered
  12.1.3 GE Healthcare Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 GE Healthcare News
12.2 Bracco Imaging
  12.2.1 Company Details
  12.2.2 Nuclear Medicine Product Offered
  12.2.3 Bracco Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Bracco Imaging News
12.3 Mallinckrodt
  12.3.1 Company Details
  12.3.2 Nuclear Medicine Product Offered
  12.3.3 Mallinckrodt Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Mallinckrodt News
12.4 Lantheus Medical Imaging
  12.4.1 Company Details
  12.4.2 Nuclear Medicine Product Offered
  12.4.3 Lantheus Medical Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Lantheus Medical Imaging News
12.5 Bayer
  12.5.1 Company Details
  12.5.2 Nuclear Medicine Product Offered
  12.5.3 Bayer Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Bayer News
12.6 Triad Isotopes
  12.6.1 Company Details
  12.6.2 Nuclear Medicine Product Offered
  12.6.3 Triad Isotopes Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Triad Isotopes News
12.7 Nordion
  12.7.1 Company Details
  12.7.2 Nuclear Medicine Product Offered
  12.7.3 Nordion Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Nordion News
12.8 Jubilant Pharma
  12.8.1 Company Details
  12.8.2 Nuclear Medicine Product Offered
  12.8.3 Jubilant Pharma Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Jubilant Pharma News
12.9 Eli Lilly
  12.9.1 Company Details
  12.9.2 Nuclear Medicine Product Offered
  12.9.3 Eli Lilly Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Eli Lilly News
12.10 SIEMENS
  12.10.1 Company Details
  12.10.2 Nuclear Medicine Product Offered
  12.10.3 SIEMENS Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 SIEMENS News
12.11 China Isotope & Radiation
12.12 Dongcheng

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nuclear Medicine
Table Product Specifications of Nuclear Medicine
Figure Nuclear Medicine Report Years Considered
Figure Market Research Methodology
Figure Global Nuclear Medicine Consumption Growth Rate 2013-2023 (M Dose)
Figure Global Nuclear Medicine Value Growth Rate 2013-2023 ($ Millions)
Table Nuclear Medicine Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Tc-99
Table Major Players of Tc-99
Figure Product Picture of I-123/131
Table Major Players of I-123/131
Figure Product Picture of In-111
Table Major Players of In-111
Figure Product Picture of Xe-133
Table Major Players of Xe-133
Figure Product Picture of Th-201
Table Major Players of Th-201
Figure Product Picture of Ga-67
Table Major Players of Ga-67
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Nuclear Medicine Consumption Market Share by Type (2013-2018)
Figure Global Nuclear Medicine Consumption Market Share by Type (2013-2018)
Table Global Nuclear Medicine Revenue by Type (2013-2018) ($ million)
Table Global Nuclear Medicine Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Nuclear Medicine Value Market Share by Type (2013-2018)
Table Global Nuclear Medicine Sale Price by Type (2013-2018)
Figure Nuclear Medicine Consumed in Diagnostic
Figure Global Nuclear Medicine Market: Diagnostic (2013-2018) (M Dose)
Figure Global Nuclear Medicine Market: Diagnostic (2013-2018) ($ Millions)
Figure Global Diagnostic YoY Growth ($ Millions)
Figure Nuclear Medicine Consumed in Therapeutic
Figure Global Nuclear Medicine Market: Therapeutic (2013-2018) (M Dose)
Figure Global Nuclear Medicine Market: Therapeutic (2013-2018) ($ Millions)
Figure Global Therapeutic YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Nuclear Medicine Consumption Market Share by Application (2013-2018)
Figure Global Nuclear Medicine Consumption Market Share by Application (2013-2018)
Table Global Nuclear Medicine Value by Application (2013-2018)
Table Global Nuclear Medicine Value Market Share by Application (2013-2018)
Figure Global Nuclear Medicine Value Market Share by Application (2013-2018)
Table Global Nuclear Medicine Sale Price by Application (2013-2018)
Table Global Nuclear Medicine Sales by Players (2016-2018) (M Dose)
Table Global Nuclear Medicine Sales Market Share by Players (2016-2018)
Figure Global Nuclear Medicine Sales Market Share by Players in 2016
Figure Global Nuclear Medicine Sales Market Share by Players in 2017
Table Global Nuclear Medicine Revenue by Players (2016-2018) ($ Millions)
Table Global Nuclear Medicine Revenue Market Share by Players (2016-2018)
Figure Global Nuclear Medicine Revenue Market Share by Players in 2016
Figure Global Nuclear Medicine Revenue Market Share by Players in 2017
Table Global Nuclear Medicine Sale Price by Players (2016-2018)
Figure Global Nuclear Medicine Sale Price by Players in 2017
Table Global Nuclear Medicine Manufacturing Base Distribution and Sales Area by Players
Table Players Nuclear Medicine Products Offered
Table Nuclear Medicine Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Nuclear Medicine Consumption by Regions 2013-2018 (M Dose)
Table Global Nuclear Medicine Consumption Market Share by Regions 2013-2018
Figure Global Nuclear Medicine Consumption Market Share by Regions 2013-2018
Table Global Nuclear Medicine Value by Regions 2013-2018 ($ Millions)
Table Global Nuclear Medicine Value Market Share by Regions 2013-2018
Figure Global Nuclear Medicine Value Market Share by Regions 2013-2018
Figure Americas Nuclear Medicine Consumption 2013-2018 (M Dose)
Figure Americas Nuclear Medicine Value 2013-2018 ($ Millions)
Figure APAC Nuclear Medicine Consumption 2013-2018 (M Dose)
Figure APAC Nuclear Medicine Value 2013-2018 ($ Millions)
Figure Europe Nuclear Medicine Consumption 2013-2018 (M Dose)
Figure Europe Nuclear Medicine Value 2013-2018 ($ Millions)
Figure Middle East & Africa Nuclear Medicine Consumption 2013-2018 (M Dose)
Figure Middle East & Africa Nuclear Medicine Value 2013-2018 ($ Millions)
Table Americas Nuclear Medicine Consumption by Countries (2013-2018) (M Dose)
Table Americas Nuclear Medicine Consumption Market Share by Countries (2013-2018)
Figure Americas Nuclear Medicine Consumption Market Share by Countries in 2017
Table Americas Nuclear Medicine Value by Countries (2013-2018) ($ Millions)
Table Americas Nuclear Medicine Value Market Share by Countries (2013-2018)
Figure Americas Nuclear Medicine Value Market Share by Countries in 2017
Table Americas Nuclear Medicine Consumption by Type (2013-2018) (M Dose)
Table Americas Nuclear Medicine Consumption Market Share by Type (2013-2018)
Figure Americas Nuclear Medicine Consumption Market Share by Type in 2017
Table Americas Nuclear Medicine Consumption by Application (2013-2018) (M Dose)
Table Americas Nuclear Medicine Consumption Market Share by Application (2013-2018)
Figure Americas Nuclear Medicine Consumption Market Share by Application in 2017
Figure United States Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure United States Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Canada Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Canada Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Mexico Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Mexico Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Table APAC Nuclear Medicine Consumption by Countries (2013-2018) (M Dose)
Table APAC Nuclear Medicine Consumption Market Share by Countries (2013-2018)
Figure APAC Nuclear Medicine Consumption Market Share by Countries in 2017
Table APAC Nuclear Medicine Value by Countries (2013-2018) ($ Millions)
Table APAC Nuclear Medicine Value Market Share by Countries (2013-2018)
Figure APAC Nuclear Medicine Value Market Share by Countries in 2017
Table APAC Nuclear Medicine Consumption by Type (2013-2018) (M Dose)
Table APAC Nuclear Medicine Consumption Market Share by Type (2013-2018)
Figure APAC Nuclear Medicine Consumption Market Share by Type in 2017
Table APAC Nuclear Medicine Consumption by Application (2013-2018) (M Dose)
Table APAC Nuclear Medicine Consumption Market Share by Application (2013-2018)
Figure APAC Nuclear Medicine Consumption Market Share by Application in 2017
Figure China Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure China Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Japan Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Japan Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Korea Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Korea Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Southeast Asia Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure India Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure India Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Australia Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Australia Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Table Europe Nuclear Medicine Consumption by Countries (2013-2018) (M Dose)
Table Europe Nuclear Medicine Consumption Market Share by Countries (2013-2018)
Figure Europe Nuclear Medicine Consumption Market Share by Countries in 2017
Table Europe Nuclear Medicine Value by Countries (2013-2018) ($ Millions)
Table Europe Nuclear Medicine Value Market Share by Countries (2013-2018)
Figure Europe Nuclear Medicine Value Market Share by Countries in 2017
Table Europe Nuclear Medicine Consumption by Type (2013-2018) (M Dose)
Table Europe Nuclear Medicine Consumption Market Share by Type (2013-2018)
Figure Europe Nuclear Medicine Consumption Market Share by Type in 2017
Table Europe Nuclear Medicine Consumption by Application (2013-2018) (M Dose)
Table Europe Nuclear Medicine Consumption Market Share by Application (2013-2018)
Figure Europe Nuclear Medicine Consumption Market Share by Application in 2017
Figure Germany Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Germany Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure France Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure France Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure UK Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure UK Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Italy Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Italy Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Russia Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Russia Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Spain Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Spain Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Nuclear Medicine Consumption by Countries (2013-2018) (M Dose)
Table Middle East & Africa Nuclear Medicine Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Nuclear Medicine Consumption Market Share by Countries in 2017
Table Middle East & Africa Nuclear Medicine Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Nuclear Medicine Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Nuclear Medicine Value Market Share by Countries in 2017
Table Middle East & Africa Nuclear Medicine Consumption by Type (2013-2018) (M Dose)
Table Middle East & Africa Nuclear Medicine Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Nuclear Medicine Consumption Market Share by Type in 2017
Table Middle East & Africa Nuclear Medicine Consumption by Application (2013-2018) (M Dose)
Table Middle East & Africa Nuclear Medicine Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Nuclear Medicine Consumption Market Share by Application in 2017
Figure Egypt Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Egypt Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure South Africa Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure South Africa Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Israel Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Israel Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure Turkey Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure Turkey Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Nuclear Medicine Consumption Growth 2013-2018 (M Dose)
Figure GCC Countries Nuclear Medicine Value Growth 2013-2018 ($ Millions)
Table Nuclear Medicine Distributors List
Table Nuclear Medicine Customer List
Figure Global Nuclear Medicine Consumption Growth Rate Forecast (2018-2023) (M Dose)
Figure Global Nuclear Medicine Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Nuclear Medicine Consumption Forecast by Countries (2018-2023) (M Dose)
Table Global Nuclear Medicine Consumption Market Forecast by Regions
Table Global Nuclear Medicine Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Nuclear Medicine Value Market Share Forecast by Regions
Figure Americas Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Americas Nuclear Medicine Value 2018-2023 ($ Millions)
Figure APAC Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure APAC Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Europe Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Europe Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Middle East & Africa Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Middle East & Africa Nuclear Medicine Value 2018-2023 ($ Millions)
Figure United States Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure United States Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Canada Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Canada Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Mexico Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Mexico Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Brazil Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Brazil Nuclear Medicine Value 2018-2023 ($ Millions)
Figure China Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure China Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Japan Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Japan Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Korea Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Korea Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Southeast Asia Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Southeast Asia Nuclear Medicine Value 2018-2023 ($ Millions)
Figure India Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure India Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Australia Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Australia Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Germany Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Germany Nuclear Medicine Value 2018-2023 ($ Millions)
Figure France Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure France Nuclear Medicine Value 2018-2023 ($ Millions)
Figure UK Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure UK Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Italy Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Italy Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Russia Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Russia Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Spain Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Spain Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Egypt Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Egypt Nuclear Medicine Value 2018-2023 ($ Millions)
Figure South Africa Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure South Africa Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Israel Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Israel Nuclear Medicine Value 2018-2023 ($ Millions)
Figure Turkey Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure Turkey Nuclear Medicine Value 2018-2023 ($ Millions)
Figure GCC Countries Nuclear Medicine Consumption 2018-2023 (M Dose)
Figure GCC Countries Nuclear Medicine Value 2018-2023 ($ Millions)
Table Global Nuclear Medicine Consumption Forecast by Type (2018-2023) (M Dose)
Table Global Nuclear Medicine Consumption Market Share Forecast by Type (2018-2023)
Table Global Nuclear Medicine Value Forecast by Type (2018-2023) ($ Millions)
Table Global Nuclear Medicine Value Market Share Forecast by Type (2018-2023)
Table Global Nuclear Medicine Consumption Forecast by Application (2018-2023) (M Dose)
Table Global Nuclear Medicine Consumption Market Share Forecast by Application (2018-2023)
Table Global Nuclear Medicine Value Forecast by Application (2018-2023) ($ Millions)
Table Global Nuclear Medicine Value Market Share Forecast by Application (2018-2023)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GE Healthcare Nuclear Medicine Market Share (2016-2018)
Table Bracco Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bracco Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bracco Imaging Nuclear Medicine Market Share (2016-2018)
Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mallinckrodt Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mallinckrodt Nuclear Medicine Market Share (2016-2018)
Table Lantheus Medical Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Medical Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lantheus Medical Imaging Nuclear Medicine Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Nuclear Medicine Market Share (2016-2018)
Table Triad Isotopes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Triad Isotopes Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Triad Isotopes Nuclear Medicine Market Share (2016-2018)
Table Nordion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nordion Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Nordion Nuclear Medicine Market Share (2016-2018)
Table Jubilant Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jubilant Pharma Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Jubilant Pharma Nuclear Medicine Market Share (2016-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly Nuclear Medicine Market Share (2016-2018)
Table SIEMENS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SIEMENS Nuclear Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure SIEMENS Nuclear Medicine Market Share (2016-2018)
Table China Isotope & Radiation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dongcheng Basic Information, Manufacturing Base, Sales Area and Its Competitors